Christine A. Nash's most recent trade in Rallybio Corp was a trade of 28,500 Option (Right to Buy) done . Disclosure was reported to the exchange on May 13, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rallybio Corp | Christine A. Nash | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2025 | 28,500 | 28,500 | - | - | Option (Right to Buy) | |
| Rallybio Corp | Christine A. Nash | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 16,500 | 16,500 | - | - | Option (Right to Buy) | |
| Rallybio Corp | Christine A. Nash | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 2,240 | 2,240 | - | - | Option (Right to Buy) | |
| Rallybio Corp | Christine A. Nash | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2022 | 26,880 | 26,880 | - | - | Option (Right to Buy) |